FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Drings

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Physiology

Genetic Predisposition to Disease

Co-author Network

Publications

TOP 3
D B Scherf; Heike Dally; P Müller; Gisela Werle-Schneider; Birgit Jäger; Lutz Edler; Siegfried Tuengerthal; JR Fischer; Peter Drings; Helmut Bartsch; Angela Risch
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.
Phillip J Müller; Heike Dally; Cornelia N Klappenecker; Lutz Edler; Birgit Jäger; Martina Gerst; Bertold Spiegelhalder; Siegfried Tuengerthal; JR Fischer; Peter Drings; Helmut Bartsch; Angela Risch
Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
Kirstin Mittelstrass; Wiebke Sauter; Albert Rosenberger; Thomas Illig; Maria Timofeeva; Norman Klopp; Hendrik Dienemann; Eckart Meese; Gerhard Sybrecht; Gabi Woelke; Mathias Cebulla; Maria Degen; Harald Morr; Peter Drings; Andreas Groeschel; Karsten Grosse Kreymborg; Karl Häußinger; Gerd Hoeffken; Christine Schmidt; Bettina Jilge; Wilhelm Schmidt; You-Dschun Ko; Dagmar Taeuscher; Jenny Chang-Claude; Heinz-Erich Wichmann; Heike Bickeboeller; Angela Risch
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Drings (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: D B Scherf; Heike Dally; P Müller; Gisela Werle-Schneider; Birgit Jäger; Lutz Edler; Siegfried Tuengerthal; JR Fischer; Peter Drings; Helmut Bartsch; Angela Risch
Single nucleotide polymorphisms in matrix metalloproteinase genes and lung cancer chemotherapy response and prognosis.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010;35(2):381-90.
2009: Phillip J Müller; Heike Dally; Cornelia N Klappenecker; Lutz Edler; Birgit Jäger; Martina Gerst; Bertold Spiegelhalder; Siegfried Tuengerthal; JR Fischer; Peter Drings; Helmut Bartsch; Angela Risch
Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients.
International journal of cancer. Journal international du cancer 2009;124(7):1669-74.
2008: Kirstin Mittelstrass; Wiebke Sauter; Albert Rosenberger; Thomas Illig; Maria Timofeeva; Norman Klopp; Hendrik Dienemann; Eckart Meese; Gerhard Sybrecht; Gabi Woelke; Mathias Cebulla; Maria Degen; Harald Morr; Peter Drings; Andreas Groeschel; Karsten Grosse Kreymborg; Karl Häußinger; Gerd Hoeffken; Christine Schmidt; Bettina Jilge; Wilhelm Schmidt; You-Dschun Ko; Dagmar Taeuscher; Jenny Chang-Claude; Heinz-Erich Wichmann; Heike Bickeboeller; Angela Risch
Early onset lung cancer, cigarette smoking and the SNP309 of the murine double minute-2 (MDM2) gene.
BMC cancer 2008;8():113.
2008: Albert Rosenberger; Thomas Illig; Katrin Korb; Norman Klopp; Vera Zietemann; Gabi Wölke; Eckart Meese; Gerhard Sybrecht; Florian Kronenberg; Matthias Cebulla; Maria Degen; Peter Drings; Andreas Gröschel; Nikolaus Konietzko; Karsten Grosse Kreymborg; Karl Häußinger; Gerd Höffken; Bettina Jilge; You-Dschun Ko; Harald Morr; Christine Schmidt; E-Wilhelm Schmidt; Dagmar Täuscher; Heike Bickeböller; H-Erich Wichmann
Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years.
BMC cancer 2008;8():60.
2007: Erika Buchholz; Christian Manegold; Lothar Pilz; Nick Thatcher; Peter Drings
Standard versus dose-intensified chemotherapy with sequential reinfusion of hematopoietic progenitor cells in small cell lung cancer patients with favorable prognosis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(1):51-8.
2005: Sebastian Aulmann; Philipp A Schnabel; Birgit Helmchen; Hendrik Dienemann; Peter Drings; Herwart F Otto; Hans-Peter Sinn
Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast.
Virchows Archiv : an international journal of pathology 2005;446(3):305-9.
2005: Gunnar Birgegård; Matti S Aapro; Carsten Bokemeyer; Mario Dicato; Peter Drings; Javier Hornedo; Maciej Krzakowski; Heinz Ludwig; Sergio Pecorelli; Hans Schmoll; Maurice Schneider; Dirk Schrijvers; Daniel Shasha; Simon van Belle
Cancer-related anemia: pathogenesis, prevalence and treatment.
Oncology 2005;68 Suppl 1():3-11.
2004: Dorota Butkiewicz; Odilia Popanda; Angela Risch; Lutz Edler; Hendrik Dienemann; Volker Schulz; Klaus Kayser; Peter Drings; Helmut Bartsch; Peter Schmezer
Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(12):2242-6.
2004: Odilia Popanda; Torsten Schattenberg; Chi Tai Phong; Dorota Butkiewicz; Angela Risch; Lutz Edler; Klaus Kayser; Hendrik Dienemann; Volker Schulz; Peter Drings; Helmut Bartsch; Peter Schmezer
Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Carcinogenesis 2004;25(12):2433-41.
2004: Heike Dally; Helmut Bartsch; Birgit Jäger; Lutz Edler; Peter Schmezer; Bertold Spiegelhalder; Hendrik Dienemann; Peter Drings; Klaus Kayser; Volker Schulz; Angela Risch
Genotype relationships in the CYP3A locus in Caucasians.
Cancer letters 2004;207(1):95-9.
2004: Young-Min A Lee; Yunhai Cui; Jörg König; Angela Risch; Birgit Jäger; Peter Drings; Helmut Bartsch; Dietrich Keppler; Anne T Nies
Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3).
Pharmacogenetics 2004;14(4):213-23.
2003: Heike Dally; Lutz Edler; Birgit Jäger; Peter Schmezer; Bertold Spiegelhalder; Hendrik Dienemann; Peter Drings; Volker Schulz; Klaus Kayser; Helmut Bartsch; Angela Risch
The CYP3A4*1B allele increases risk for small cell lung cancer: effect of gender and smoking dose.
Pharmacogenetics 2003;13(10):607-18.
2003: Minne van der Haak; Astrid Corinna Wolff; Ralf Brandner; Peter Drings; Michael Wannenmacher; Thomas Wetter
Data security and protection in cross-institutional electronic patient records.
International journal of medical informatics 2003;70(2-3):117-30.
2003: Thomas Muley; Werner Ebert; Petra Stieber; Hannelore Raith; Stefan Holdenrieder; Dorothea Nagel; Heinrich Fürst; Heinz-Jürgen Roth; Hilmar Luthe; Bert G Blijenberg; Eberhard Gurr; Wolfgang Uhl; Joachim von Pawel; Peter Drings
Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2003;41(1):95-103.
2002: Heike Dally; Kai Gassner; Birgit Jäger; Peter Schmezer; Bertold Spiegelhalder; Lutz Edler; Peter Drings; Hendrik Dienemann; Volker Schulz; Klaus Kayser; Helmut Bartsch; Angela Risch
Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO -463 A allele is associated with reduced risk for small cell lung cancer in smokers.
International journal of cancer. Journal international du cancer 2002;102(5):530-5.
2002: Roger Godschalk; Urmila Nair; Frederik J Van Schooten; Angela Risch; Peter Drings; Klaus Kayser; Hendrik Dienemann; Helmut Bartsch
Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: effect of cigarette smoking.
Carcinogenesis 2002;23(12):2081-6.
2002: JR Fischer; P Baas; H D Becker; Lech Chyczewski; Hendrik Dienemann; Peter Drings; Werner Ebert; Felix Herth; H Hoffmann; Jerzy Laudanski; Harald Lahm; Ch Manegold; Mariano Monzó; W J Mooi; Thomas Muley; A Neuner; Jacek Niklinski; Wieslawa Niklinska; Rafael Rosell; Miquel Taron; L van't Veer; Bernd Werle; N v Zandwijk
Report from the first meeting of the 'European Network on Translational Research in Lung Cancer Amsterdam-Barcelona-Bialystok-Heidelberg'. Thoraxklinik Heidelberg, Germany, July 25, 2001.
Lung cancer (Amsterdam, Netherlands) 2002;36(2):221-4.
2002: Werner Ebert; Thomas Muley; Christine Trainer; Hendrik Dienemann; Peter Drings
Comparison of changes in the NSE levels with clinical assessment in the therapy monitoring of patients with SCLC.
Anticancer research 2002;22(2B):1083-9.
2002: Minne van der Haak; Astrid Corinna Wolff; Volker Mludek; Peter Drings; Michael Wannenmacher; Thomas Wetter
Data security and protection in cross-institutional electronic patient records.
Studies in health technology and informatics 2002;90():341-5.
2002: Minne van der Haak; Volker Mludek; Astrid Corinna Wolff; Heinrich Bülzebruck; Dieter Oetzel; Dietmar Zierhut; Peter Drings; Michael Wannenmacher; Reinhold Haux
Networking in shared care--first steps towards a shared electronic patient record for cancer patients.
Methods of information in medicine 2002;41(5):419-25.
2001: Angela Risch; H Wikman; S Thiel; Peter Schmezer; Lutz Edler; Peter Drings; Hendrik Dienemann; Klaus Kayser; Volker Schulz; Bertold Spiegelhalder; Helmut Bartsch
Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
Pharmacogenetics 2001;11(9):757-64.
2001: JR Fischer; A Neuner; Thomas Muley; Harald Lahm; Peter Drings
[Immunobiology of the non-small-cell lung carcinoma: new aspects].
Onkologie 2001;24 Suppl 5():72-4.
2001: Felix Herth; H D Becker; C Manegold; Peter Drings
Endobronchial ultrasound (EBUS)--assessment of a new diagnostic tool in bronchoscopy for staging of lung cancer.
Onkologie 2001;24(2):151-4.
2001: Jeannine Lacroix; H D Becker; Stefan M Woerner; Werner Rittgen; Peter Drings; Magnus von Knebel Doeberitz
Sensitive detection of rare cancer cells in sputum and peripheral blood samples of patients with lung cancer by preproGRP-specific RT-PCR.
International journal of cancer. Journal international du cancer 2001;92(1):1-8.
2001: Nahid Rajaee-Behbahani; Peter Schmezer; Angela Risch; Werner Rittgen; Klaus Kayser; Hendrik Dienemann; Volker Schulz; Peter Drings; S Thiel; Helmut Bartsch
Altered DNA repair capacity and bleomycin sensitivity as risk markers for non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2001;95(2):86-91.
2001: H Wikman; S Thiel; Birgit Jäger; Peter Schmezer; Bertold Spiegelhalder; Lutz Edler; Hendrik Dienemann; Klaus Kayser; Volker Schulz; Peter Drings; Helmut Bartsch; Angela Risch
Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Pharmacogenetics 2001;11(2):157-68.
2001: Astrid Corinna Wolff; Volker Mludek; Minne van der Haak; W Bork; Heinrich Bülzebruck; Peter Drings; P Schmücker; Michael Wannenmacher; Reinhold Haux
Using the eXtensible Markup Language (XML) in a regional electronic patient record for patients with malignant diseases.
Studies in health technology and informatics 2001;84(Pt 1):698-702.
2001: Volker Mludek; Astrid Corinna Wolff; Peter Drings; Minne van der Haak; Reinhold Haux; Michael Wannenmacher; Dietmar Zierhut
Integration of clinical practice guidelines into a distributed regional electronic patient record for tumour-patients using XML: a means for standardization of the treatment processes.
Studies in health technology and informatics 2001;84(Pt 1):658-62.
2001: Peter Schmezer; Nahid Rajaee-Behbahani; Angela Risch; S Thiel; Werner Rittgen; Peter Drings; Hendrik Dienemann; Klaus Kayser; Volker Schulz; Helmut Bartsch
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes.
Mutagenesis 2001;16(1):25-30.
2000: H Wikman; Angela Risch; Fritz Klimek; Peter Schmezer; Bertold Spiegelhalder; Hendrik Dienemann; Klaus Kayser; Volker Schulz; Peter Drings; Helmut Bartsch
hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population.
International journal of cancer. Journal international du cancer 2000;88(6):932-7.
2000: JR Fischer; M Schindel; Heinrich Bülzebruck; Harald Lahm; P H Krammer; Peter Drings
Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis.
Journal of cancer research and clinical oncology 2000;126(12):730-3.
1999: W W ten Bokkel Huinink; B Bergman; A Chemaissani; W Dornoff; Peter Drings; P L Kellokumpu-Lehtinen; K Liippo; Karin Mattson; Joachim von Pawel; S Ricci; C Sederholm; R A Stahel; G Wagenius; N V Walree; C Manegold
Single-agent gemcitabine: an active and better tolerated alternative to standard cisplatin-based chemotherapy in locally advanced or metastatic non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;26(2):85-94.
1998: Manfred Volm; Werner Rittgen; Peter Drings
Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas.
British journal of cancer 1998;77(4):663-9.
1998: J R Fischer; Peter Drings
Role of vindesine in induction chemotherapy in locally-advanced non-small-cell lung cancer.
Journal of cancer research and clinical oncology 1998;124(1):4-9.
1997: JR Fischer; M Schindel; Harald Lahm; Peter Drings
Tumour-derived, endocrine, exogenous and therapeutic factors differentially modulate cytokine secretion in whole blood cell culture.
European journal of cancer (Oxford, England : 1990) 1997;33(10):1661-7.
1997: Werner Ebert; M Hoppe; Thomas Muley; Peter Drings
Monitoring of therapy in inoperable lung cancer patients by measurement of CYFRA 21-1, TPA- TP CEA, and NSE.
Anticancer research 1997;17(4B):2875-8.
1997: C Manegold; B Bergman; A Chemaissani; W Dornoff; Peter Drings; P Kellokumpu-Lehtinen; K Liippo; Karin Mattson; J van Pawel; S Ricci; C Sederholm; R A Stahel; G Wagenius; N van Walree; W ten Bokkel-Huinink
Single-agent gemcitabine versus cisplatin-etoposide: early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(6):525-9.
1997: C Manegold; Peter Drings; Joachim von Pawel; S Ricci; W Dornoff; N van Walree; W ten Bokkel Huinink; A Chemaissani; P Stahel; B Bergman; G Wagenius; C Sederholm; Karin Mattson; K Liippo; P Kellokumpu-Lehtinen
A randomized study of gemcitabine monotherapy versus etoposide/cisplatin in the treatment of locally advanced or metastatic non-small cell lung cancer.
Seminars in oncology 1997;24(3 Suppl 8):S8-13-S8-17.
1997: JR Fischer; M Schindel; Heinrich Bülzebruck; Harald Lahm; P H Krammer; Peter Drings
Decrease of interleukin-2 secretion is a new independent prognostic factor associated with poor survival in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):457-61.
1996: C Manegold; J Schirren; P Schneider; Peter Drings; I Vogt-Moykopf; P Schraube; Michael Wannenmacher
[Current status of interdisciplinary therapy of stage III non-small-cell bronchial carcinoma].
Pneumologie (Stuttgart, Germany) 1996;50(10):735-41.
1995: JR Fischer; M Schindel; N Stein; Harald Lahm; H Gallati; P H Krammer; Peter Drings
Selective suppression of cytokine secretion in patients with small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(9):921-6.
1994: JR Fischer; C Manegold; Heinrich Bülzebruck; I Vogt-Moykopf; Peter Drings
Induction chemotherapy with and without recombinant human granulocyte colony-stimulating factor support in locally advanced stage IIIA/B non-small cell lung cancer.
Seminars in oncology 1994;21(3 Suppl 4):20-7.
1994: JR Fischer; H Darjes; Harald Lahm; M Schindel; Peter Drings; P H Krammer
Constitutive secretion of bioactive transforming growth factor beta 1 by small cell lung cancer cell lines.
European journal of cancer (Oxford, England : 1990) 1994;30A(14):2125-9.
1992: C Manegold; H Bischoff; JR Fischer; S Löchner; M Peukert; A Schmähl; Peter Drings
Oral ifosfamide-mesna: a clinical investigation in advanced non-small-cell lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):723-6.
1991: M Wolf; R Holle; K Hans; Peter Drings; Klaus Havemann
Analysis of prognostic factors in 766 patients with small cell lung cancer (SCLC): the role of sex as a predictor for survival.
British journal of cancer 1991;63(6):986-92.
1991: M Wolf; M Pritsch; Peter Drings; K Hans; M Schroeder; H Flechtner; M Heim; D Hruska; S Mende; H Becker
Cyclic-alternating versus response-oriented chemotherapy in small-cell lung cancer: a German multicenter randomized trial of 321 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):614-24.
1989: C Manegold; Heinrich Bülzebruck; Peter Drings; I Vogt-Moykopf
[Prognostic factors in small cell bronchial cancer].
Onkologie 1989;12(5):240-5.
1989: C Manegold; Burkhardt Krempien; G Mall; Peter Drings
[Possibilities and limits of ilial crest punch biopsy in the diagnosis of bone metastases of solid tumors].
Der Pathologe 1989;10(2):118-24.
1989: Klaus Havemann; M Wolf; Peter Drings; K Hans; M Schroeder; R Holle; H Flechtner; R Goerg; H Becker
Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
Seminars in oncology 1989;16(1 Suppl 3):9-18.
1989: Peter Drings
European experience with ifosfamide in non-small cell lung cancer.
Seminars in oncology 1989;16(1 Suppl 3):22-30.
1989: C Manegold; Burkhardt Krempien; Heinrich Bülzebruck; Peter Drings
Value of bilateral iliac crest needle biopsy for pretherapeutic tumor staging of bronchogenic carcinomas.
Oncology 1989;46(4):226-9.
1988: Peter Drings; H Becker; H Bülzebruck; N Djawid; E Ruchalla; P Stiefel; H W Tessen
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
Onkologie 1988;11 Suppl 2():47-56.
1987: Peter Drings; A Calcanis
[Furtulon (doxifluridine) in the treatment of non-small cell bronchial carcinoma].
Onkologie 1987;10(6):376-7.
1987: M Wolf; Klaus Havemann; R Holle; Peter Drings; K Hans; M Schroeder
[Incidence of recurrence and long-term survival in small cell bronchial carcinoma].
Onkologie 1987;10(6):357-66.
1987: M Wolf; Klaus Havemann; R Holle; C Gropp; Peter Drings; K Hans; M Schroeder; M Heim; M Dommes; S Mende
Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(12):1880-9.
1987: M Wolf; Klaus Havemann; R Holle; V Harms; Peter Drings; K Hans; H Dombrowski; N Victor
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial.
European journal of cancer & clinical oncology 1987;23(8):1197-205.
1987: Klaus Havemann; M Wolf; R Holle; C Gropp; Peter Drings; H G Manke; K Hans; M Schroeder; M Heim; N Victor
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
Cancer 1987;59(6):1072-82.
1986: Peter Drings; H Bülzebruck; D Hruska; H G Manke; G Schuler
[EPICO in the treatment of small cell bronchial cancer. 3. Intermediate analysis].
Onkologie 1986;9 Suppl 1():14-20.
1986: Klaus Havemann; C Gropp; J Klapsing; N Viktor; R Holle; Peter Drings; H G Manke; K Hans; M Schroeder; M Heim
Two randomized trials for alternating polychemotherapy of small cell lung cancer.
Cancer chemotherapy and pharmacology 1986;18 Suppl 2():S40-4.
1986: Peter Drings; U Abel; H Bülzebruck; P Stiefel; M Kleckow; H G Manke
Experience with ifosfamide combinations (etoposide or DDP) in non-small cell lung cancer.
Cancer chemotherapy and pharmacology 1986;18 Suppl 2():S34-9.
1984: Peter Drings; M Kleckow; H G Manke; E Stiefel
[Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
Onkologie 1984;7(4):202-4.
1984: Peter Drings; P Stiefel; H P Dirks; V Grimm; M Kleckow; H G Manke; W Queisser; U Abel; S Heinrich
[Chemotherapy of the non-small cell carcinoma of the lung with ifosfamide and cisplatin].
Deutsche medizinische Wochenschrift (1946) 1984;109(27):1059-64.
1984: A Liesenfeld; Klaus Havemann; C Gropp; W Seifert; C Thomas; Peter Drings; H G Mahnke; M Westerhausen; W Wellens; R M Konrad
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Onkologie 1984;7(3):145-51.
1983: M H Dörner; U Abel; D Fritze; H G Manke; Peter Drings
Serum ferritin in relation to the course of Hodgkin's disease.
Cancer 1983;52(12):2308-12.
1983: H G Manke; Peter Drings; P Stiefel; H Schmitteckert; V Grimm; M Kleckow
Combined chemotherapy with ifosfamide and cisplatin and with ifosfamide and etoposide (VP-16) in non-small cell carcinoma of the bronchus.
Cancer treatment reviews 1983;10 Suppl A():125-8.
1983: C Gropp; K Havemann; A Liesenfeld; V Harms; C Thomas; W Bischoff; Peter Drings; H G Manke; K Hans; W Westerhausen
Treatment of small cell lung cancer by different chemotherapy regimes.
Cancer treatment reviews 1983;10 Suppl A():111-20.
1983: W Weber; H Arnold; Peter Drings; G Germano; K M Müller; W Queisser; M Westerhausen; J P Obrecht
[Etretinate (Ro 10-9359, Tigason) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea) and bleomycin versus CCNU and bleomycin in the treatment of advanced squamous cell carcinoma of the bronchus (Working group on Internal Medicine Oncology Study BS1/78)].
Onkologie 1983;6(2):62-5.
1982: B Massner; I Voss; W Queisser; Peter Drings; D Fritze; M Westerhausen
[Alternative treatment with carmustine, vindesine and tamoxifen in previously cytostaticly (VAC, FMC) treated patients with metastatic breast cancer].
Onkologie 1982;5 Suppl():46-51.
1981: W Queisser; G Schnitzler; J Schaefer; H Arnold; Peter Drings; D Fritze; J Geldmacher; G Hartwich; R Herrmann; P Kempf; H König; R J Meiser; R Nedden; H F von Oldershausen; A Pappas; H Sievers; J Wahrendorf; M Westerhausen; S Witte
Comparison of ftorafur with 5-fluorouracil in combination chemotherapy of advanced gastrointestinal carcinoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1981;79():82-92.